fatty15 is the rare supplement that’s easy to describe and hard to score. Easy, because the product is a model of transparency: one ingredient, a stated dose, a vegan capsule, GRAS affirmation, batch testing. Hard, because everything that makes it interesting — the claim that C15:0 is a newly discovered essential fatty acid, that most of us are deficient, that supplementing it repairs “cellular fragility” — sits on an evidence base that independent scientists don’t yet accept.
So we score the two things separately, the way a careful shopper should: the product is excellent; the premise is unproven. Here’s the full picture.
At a glance
Quick verdict
On our rubric’s transparency measures, fatty15 scores like almost nothing else: one ingredient, one number, GRAS status, batch testing, no blends, no games. If every brand labeled this honestly, this site would be shorter. That candor is real and we credit it fully.
But transparency about what’s in the capsule can’t substitute for evidence that the capsule does something, and here the independent record is thin. C15:0 isn’t classified as essential; the “Cellular Fragility Syndrome” that frames the marketing is a recent coinage appearing mostly in the co-founder’s own work; and the two human trials that exist are small, partly company-funded, and largely null on their primary endpoints. 48/100 is a clean product held back by an unconfirmed premise and a price that assumes the premise is settled.
A consistent summary of formula, transparency, value and evidence. Not a medical rating.
Scores follow our published 100-point methodology, applied identically to every product. Where a product’s value rests on a health claim, we weigh the strength and independence of the evidence. View the scoring methodology.
May suit you if
- You want maximal label transparency and are comfortable funding an early, unproven hypothesis with your own money
- Your blood C15:0 tested genuinely low and a clinician suggested addressing it
- You value a single, clean ingredient over multi-ingredient blends — on that axis fatty15 is best-in-class
Skip it if
- You want a benefit confirmed by independent, non-company-funded human trials — those don’t exist yet
- You’d get C15:0 more cheaply from food (whole dairy, some fish) while the science matures
- The $199 add-on blood test feels like a funnel rather than a need — it often is
Plain Google search link — not an affiliate link. The Ingredient Report earns nothing if you purchase this product.
Key findings
Product specifications
| Format | Vegan capsules — 1–2 per day |
|---|---|
| Active ingredient | 100 mg pure C15:0 (pentadecanoic acid), branded ReCellience15 — single ingredient |
| Price (checked July 17, 2026) | 90-day kit $119.95 · annual $459.95 · 30-day trial $49.95 |
| Cost per day | $1.33 (90-day/annual) – $1.66 (trial) |
| Safety status | GRAS (Generally Recognized As Safe) affirmed |
| Testing claim | “Every batch independently tested” (no named standard/COA link published on-page as of this date) |
| Add-on | $199 at-home C15:0 blood test via Genova Diagnostics |
| Evidence claims | “100+ peer-reviewed studies,” “60+ patents,” U.S. Navy collaboration, GRAS/CARSE |
| Company | Seraphina Therapeutics |
The product: nearly perfect transparency
Set the science aside for a moment and just grade the label, the way we grade everyone’s. One ingredient. One number. No proprietary blend, no fairy dust, no “150 nutrients” to divide. GRAS affirmation is a real regulatory step most supplements skip, and a single-molecule product is the easiest thing in this industry to test and verify. Dosage & transparency lands at 18/20 — one of the highest marks we’ve given. Formula quality gets 12/25 not because the capsule is poorly made, but because “quality” in our rubric includes whether the ingredient does a job worth doing — and that’s exactly what’s unsettled.
The evidence: early, and mostly in-house
Here is the part the marketing rushes past. For a nutrient to have a “deficiency,” it first has to be essential — and no independent authority has classified C15:0 that way. The National Academies of Sciences, which sets nutrient requirements, doesn’t list it. The Center for Science in the Public Interest, reviewing the literature, wrote that beyond fatty15’s own co-founder’s research, it “could find only one group of investigators that is even considering whether C15:0 is essential.”
The human trials that do exist are small and conflicted. In a 12-week study of 88 women, adding C15:0 to a Mediterranean diet did “no better” than the diet alone on most measures; a 30-person pilot “partly funded by fatty15’s manufacturer” raised blood C15:0 but produced “no differences between groups in body weight, waist circumference, total cholesterol, LDL cholesterol, blood sugar, or a marker of inflammation.” The impressive-sounding “100+ peer-reviewed studies” are, on inspection, largely cell and animal mechanism papers — hypothesis-generating, not outcome-proving. None of this means C15:0 can’t matter; emerging science sometimes pans out. It means that today, in 2026, you’d be paying for a bet, and the house holds most of the research. Testing 12/20 for verifiable batch practices and GRAS; value 2/15 because the price is set as if the question were answered.
The math — and the $199 test
At $1.33–$1.66 a day, fatty15 runs $485–$605 a year. The optional $199 blood test is the part that earns a raised eyebrow: it measures a C15:0 “level” against a deficiency framework the broader field doesn’t endorse, then sells the fix. If you’re curious about C15:0, whole dairy fat and certain fish supply it in food at no marginal cost while the evidence matures. Value: 2/15 — not because the capsule is overpriced to make, but because you’re buying an unconfirmed outcome.
What customers & scientists say
We read both customer feedback and the independent scientific commentary, and summarize the recurring themes. We don’t republish other outlets’ content — check the live sources yourself:
Customer reviews
Generally positive
Many report subjective energy/skin benefits within weeks; the brand cites “70% report benefits within 16 weeks.” Subjective, uncontrolled, and expected for any wellness routine.
View live reviews →Independent scientists
Skeptical
CSPI: “Save your money.” Lipid researchers and dietitians question the essentiality claim and the company-linked evidence base.
Read CSPI’s analysis →Product integrity
Genuinely clean
Even skeptics concede the product is transparent, single-ingredient and GRAS — the dispute is the premise, not the purity.
Search the science →We don't fact-check or verify individual customer reviews — reviewers' opinions and experiences are their own, and we never treat them as evidence that a product works or doesn't. We read feedback at scale, report recurring themes, and link the live sources.
Every factual claim on this page that is ours carries a checked date and a source. Spot an error? Tell us — corrections run under our corrections policy.
Reader reports · 0 so far
Share your experienceRight of reply: Seraphina Therapeutics is welcome to respond on the record — including with independent, non-company-funded human outcome trials, which would materially change the evidence score. Contact our editorial team — responses are published unedited alongside this review.
Final assessment
fatty15 is the most honest product we’ve had to score below the midline, and that’s worth stating clearly: nothing here is hidden, adulterated or overclaimed about what’s in the capsule. If our rubric only measured transparency, it would rank near the top. But a supplement has to earn its price with evidence that it does something, and C15:0’s case rests on a not-yet-accepted theory of essentiality, small and partly self-funded human trials that mostly came back null, and a marketing apparatus — including a $199 test — built as if the debate were over. 48/100: significant concerns, of an unusual kind. If independent, adequately powered, non-company-funded human trials confirm a benefit, this score moves up fast, because the product itself is already there. Until then, you’re buying a clean capsule and an early hypothesis. This isn’t medical advice — talk with your clinician before starting any new supplement, especially if you’re managing a condition.
Frequently asked questions
What’s in it?
One ingredient: 100 mg pure C15:0 (pentadecanoic acid / ReCellience15) per vegan capsule, 1–2 a day. GRAS-affirmed, brand states every batch is independently tested (checked July 17, 2026).
Is C15:0 essential?
Not per the National Academies. CSPI found essentially no independent research group besides the co-founder pursuing the essentiality claim. It’s an emerging hypothesis, not established nutrition science.
Does it work?
The pivotal human trials are small and partly company-funded, and largely showed no advantage over control. The “100+ studies” are mostly cell/animal mechanism work. Verdict: unproven in humans as of 2026.
How much?
Checked July 17, 2026: $119.95/90-day kit (~$1.33/day), $459.95 annual (~$1.28/day), $49.95 30-day trial ($1.66/day). Optional $199 blood test.
The Label Brief — free weekly report
A perfect label around an unproven idea. Want next week’s under the same lens?
Every week we put one supplement label, one price claim and one viral promise under the same microscope. One five-minute email. No hype, no sponsored scores.
Get The Label Brief free →How we scored this product
Every product is scored with the same public 100-point methodology: formula and ingredient quality (25%), dosage and label transparency (20%), testing and manufacturing transparency (20%), value (15%), product experience (10%) and brand and customer experience (10%). Where a product’s value depends on a health claim, we weigh the strength and independence of the evidence. Commercial relationships never add points. Read the full methodology.
Sources
- fatty15 — fatty15.com product page (100 mg C15:0/ReCellience15 per capsule; 90-day kit $119.95, annual $459.95, 30-day trial $49.95; GRAS; “every batch independently tested”; “100+ studies,” “60+ patents”; $199 Genova blood test; Seraphina Therapeutics). Checked July 17, 2026.
- Center for Science in the Public Interest — “Is Fatty15 worth the hype?” (essentiality not recognized; “Cellular Fragility Syndrome” coined recently and confined largely to co-founder’s work; 88-woman trial “no better” than diet; 30-adult pilot partly manufacturer-funded, null on primary endpoints; “Save your money”). Accessed July 17, 2026. cspi.org
- National Academies of Sciences, Engineering, and Medicine — Dietary Reference Intakes (C15:0 not classified as an essential fatty acid). Referenced July 17, 2026.
- Customer and independent-review aggregators (feedback and expert-commentary themes; linked live, not republished). Accessed July 17, 2026.
Update history
- July 17, 2026 — Report first published from product-page facts and independent scientific commentary checked this date. We have not yet purchased this product; label figures are as stated by the brand and cited sources, and a hands-on purchase (with label photography) is planned. Standing re-score offer: independent, adequately powered, non-company-funded human outcome trials.
Content is for informational purposes only and is not medical advice. Individual needs vary — consult your healthcare provider. Medical disclaimer.